Hologic Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 5.98, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the first quarter 2026. Average receivable collection period, for the Hologic Inc in Dec 27 2025 quarter, has decreased to 61 days, compared to 67 days, in the Sep 27 2025 quarter.

If we take a look into Healthcare sector 329 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 27 2025 from 1792 to 2524.

What is Receivable Turnover Ratio?
What is Hologic Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HOLX Receivables Turnover Ratio	(Dec 27 2025) I. Quarter	(Sep 27 2025) IV. Quarter	(Jun 28 2025) III. Quarter	(Mar 29 2025) II. Quarter	(Dec 28 2024) I. Quarter
Y / Y Receivable Change	-7.48 %	0.07 %	-3.05 %	-0.42 %	-5.89 %
Y / Y Revenue Change	44.84 %	71.51 %	2.2 %	-58.21 %	-38.16 %
Receivable Turnover Ratio (TTM)	5.98	5.41	4.28	4.22	5.16
HOLX's Total Ranking	# 2524	# 1792	# 1848	# 1167	# 2777
Accounts Receivable average collection period days	61	67	85	86	71
Seq. Receivable Change	-2.76 %	-1.4 %	-5.45 %	2.06 %	5.16 %
Seq. Revenue Change	-46.45 %	174.37 %	45.22 %	-32.11 %	-36.59 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 21
Healthcare Sector	# 330
Overall Market	# 2524

Receivable Turnover Ratio Statistics
High	Average	Low
6.91	5.67	3.29
(Dec 26 2015)		(Jun 27 2020)

HOLX Company Profile • Back to HOLX Efficiency Comparisons • Compare HOLX Receivables Turnover Ratio to its Competitors

Financial Statements
Hologic Inc's Accounts Receivable	$ 584 Millions	Visit HOLX's Balance sheet
Hologic Inc's Sales TTM	$ 3,645 Millions	Visit HOLX's Income Statement
Sources of HOLX's Revenues		Visit HOLX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
HOLX's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
HOLX's Growth Rates	HOLX's Roa	HOLX's Inventory Turnover Ratio	HOLX's Dividend Comparisons
HOLX's Profitability Ratios	HOLX's Roi	HOLX's Asset Turnover Ratio	HOLX's Dividend Growth
HOLX's Valuation Ratios	HOLX's Roe	HOLX's Financial Strength Ratios	HOLX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 27 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 27 2025	Receivable at quarter ending Dec 27 2025
Marpai Inc	16.64	$ 18.099 Millions	$ 1.088 Millions
Euda Health Holdings Limited	16.07	$ 5.993 Millions	$ 0.373 Millions
Bioage Labs Inc	16.01	$ 8.995 Millions	$ 0.562 Millions
Nutriband Inc	15.64	$ 2.037 Millions	$ 0.130 Millions
Plus Therapeutics Inc	15.53	$ 5.213 Millions	$ 0.336 Millions
Talkspace Inc	15.35	$ 228.871 Millions	$ 14.915 Millions
Nanobiotix S a	15.26	$ 36.504 Millions	$ 2.392 Millions
Gsk Plc	15.21	$ 32,667.000 Millions	$ 2,148.000 Millions
Precipio inc	15.02	$ 24.049 Millions	$ 1.601 Millions
Qhslab Inc	14.47	$ 2.692 Millions	$ 0.186 Millions
Arbutus Biopharma Corp	14.04	$ 14.083 Millions	$ 1.003 Millions
Sutro Biopharma Inc	13.92	$ 102.484 Millions	$ 7.365 Millions
Aim Immunotech Inc	13.54	$ 0.088 Millions	$ 0.007 Millions
Amneal Pharmaceuticals Inc	13.44	$ 3,018.308 Millions	$ 224.629 Millions
Inmed Pharmaceuticals Inc	13.26	$ 4.507 Millions	$ 0.340 Millions
Rosecliff Acquisition Corp I	13.19	$ 20.547 Millions	$ 1.557 Millions
Xoma Royalty Corporation	13.18	$ 52.149 Millions	$ 3.957 Millions
Nexgel Inc	13.17	$ 10.509 Millions	$ 0.798 Millions
China Pharma Holdings Inc	13.14	$ 4.144 Millions	$ 0.315 Millions
Milestone Scientific Inc	12.98	$ 8.408 Millions	$ 0.648 Millions
Escalon Medical Corp	12.93	$ 12.311 Millions	$ 0.952 Millions
Dbv Technologies S a	12.63	$ 5.683 Millions	$ 0.450 Millions
Mannkind Corporation	12.49	$ 348.966 Millions	$ 27.948 Millions
Safe Pro Group Inc	12.46	$ 0.607 Millions	$ 0.049 Millions
Icu Medical Inc	12.35	$ 2,231.262 Millions	$ 180.620 Millions
Ensysce Biosciences Inc	12.27	$ 5.067 Millions	$ 0.413 Millions
Neuroone Medical Technologies Corp	12.24	$ 8.716 Millions	$ 0.712 Millions
Skinhealth Systems Inc	12.08	$ 300.364 Millions	$ 24.872 Millions
Ptc Therapeutics inc	11.92	$ 1,730.655 Millions	$ 145.207 Millions
Corcept Therapeutics Inc	11.91	$ 761.407 Millions	$ 63.950 Millions

Date modified: 2026-09-08T18:07:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.